Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance
Abstract Background Mortality rates for patients with Staphylococcus aureus (S. aureus) infections have improved only modestly in recent decades and S. aureus infections remain a major clinical challenge This study investigated the in vitro antimicrobial activity of erevacycline (erava) against clin...
Main Authors: | Fan Zhang, Bing Bai, Guang-jian Xu, Zhi-wei Lin, Gui-qiu Li, Zhong Chen, Hang Cheng, Xiang Sun, Hong-yan Wang, Yan-wei Chen, Jin-xin Zheng, Qi-wen Deng, Zhi-jian Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Microbiology |
Online Access: | http://link.springer.com/article/10.1186/s12866-018-1349-7 |
Similar Items
-
Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China
by: Zewen Wen, et al.
Published: (2020-05-01) -
Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
by: Jiun-Ling Wang, et al.
Published: (2004-09-01) -
Efficacy and safety of eravacycline: A meta-analysis
by: Khalid Eljaaly, et al.
Published: (2021-03-01) -
Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil
by: Alessandro Conrado de Oliveira Silveira, et al.
Published: (2015-09-01) -
In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum
by: Erik Koehne, et al.
Published: (2021-03-01)